- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 1JT: 1-(4-methoxy-3-methylbenzyl)-5,6,7,8-tetrahydro-1H-naphtho[2,3-d]imidazole(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 27 residues within 4Å:- Chain A: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.1
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:I.40, A:Y.166, A:Y.166, A:A.209
- Hydrogen bonds: A:G.33, A:I.40, A:D.83, A:D.83, A:V.84, A:I.111, A:A.112, A:Y.176, A:K.183, A:I.212, A:I.212, A:A.216
- Water bridges: A:G.33, A:G.33, A:A.41, A:V.60, A:V.60, A:I.111, A:L.215
NAD.7: 26 residues within 4Å:- Chain B: G.33, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.6
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:I.40, B:Y.166, B:Y.166, B:A.209
- Hydrogen bonds: B:G.33, B:I.40, B:D.83, B:V.84, B:I.111, B:A.112, B:K.183, B:I.212, B:I.212, B:T.214, B:A.216
- Water bridges: B:G.33, B:G.33, B:A.41, B:I.111, B:L.215
NAD.13: 26 residues within 4Å:- Chain C: G.33, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.12
20 PLIP interactions:20 interactions with chain C- Hydrophobic interactions: C:I.40, C:Y.166, C:Y.166, C:A.209
- Hydrogen bonds: C:G.33, C:I.40, C:D.83, C:V.84, C:I.111, C:A.112, C:K.183, C:I.212, C:I.212, C:T.214, C:A.216
- Water bridges: C:G.33, C:G.33, C:A.41, C:I.111, C:L.215
NAD.17: 27 residues within 4Å:- Chain D: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.16
20 PLIP interactions:20 interactions with chain D- Hydrophobic interactions: D:I.40, D:Y.166, D:Y.166, D:A.209
- Hydrogen bonds: D:G.33, D:I.40, D:D.83, D:D.83, D:V.84, D:I.111, D:A.112, D:Y.176, D:K.183, D:I.212, D:I.212, D:A.216
- Water bridges: D:G.33, D:A.41, D:V.60, D:I.111
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 7 residues within 4Å:- Chain A: Y.229, Y.271, S.275, M.276
- Chain D: Y.229, S.275, M.276
6 PLIP interactions:1 interactions with chain A, 5 interactions with chain D- Hydrogen bonds: A:M.276, D:S.275, D:M.276
- Water bridges: D:V.274, D:G.277, D:G.277
GOL.8: 7 residues within 4Å:- Chain B: Y.229, Y.271, V.274, S.275, M.276
- Chain C: S.275, M.276
9 PLIP interactions:5 interactions with chain C, 4 interactions with chain B- Hydrogen bonds: C:Y.229, C:M.276, B:Y.229, B:Y.271, B:S.275, B:M.276
- Water bridges: C:V.274, C:G.277, C:G.277
GOL.9: 10 residues within 4Å:- Chain B: G.210, P.211, L.227, N.230, S.234, K.238, N.239, V.240, D.268, A.269
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:P.211, B:N.230, B:S.234, B:V.240, B:D.268
GOL.10: 6 residues within 4Å:- Chain B: E.170, A.184, E.187, A.188, R.191
- Chain D: A.184
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:A.184, B:A.188, B:R.191, B:R.191
- 3 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 3 residues within 4Å:- Chain A: F.113, P.115, R.116
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.116
- Water bridges: A:D.117
- Salt bridges: A:R.116
ACT.11: 3 residues within 4Å:- Chain B: F.113, P.115, R.116
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.116
- Water bridges: B:R.116, B:D.117
- Salt bridges: B:R.116
ACT.14: 3 residues within 4Å:- Chain C: F.113, P.115, R.116
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.116
- Water bridges: C:D.117
- Salt bridges: C:R.116
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehboob, S. et al., Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). Bioorg.Med.Chem.Lett. (2015)
- Release Date
- 2014-07-23
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 1JT: 1-(4-methoxy-3-methylbenzyl)-5,6,7,8-tetrahydro-1H-naphtho[2,3-d]imidazole(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 3 x ACT: ACETATE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehboob, S. et al., Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). Bioorg.Med.Chem.Lett. (2015)
- Release Date
- 2014-07-23
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D